News Highlights: Top Company News of the Day
19 December 2018 - 1:30PM
Dow Jones News
CBS Shifts to Hunt for Next CEO
Tom Staggs, the former operating chief of Walt Disney, has
emerged as a top candidate for the chief executive job at CBS, as
the network looks to turn the page on months of uncertainty and
upheaval since the departure of Leslie Moonves.
CVS Urges Judge Not to Halt Integration of Aetna
A federal judge softened his previous suggestion that he would
likely issue a court order requiring CVS Health to halt its
integration of newly acquired insurer Aetna, citing CVS's pledges
to keep certain aspects of Aetna's operations separate for now.
FedEx Starts Buyout Program as Express Struggles
The delivery carrier says it expects a pretax charge of up to
$575 million from the buyout plan and that it intends to cut
international capacity at FedEx Express, where performance has
weakened.
Conagra Finds New Buyer for Wesson
Canadian agribusiness firm Richardson International has agreed
to buy the cooking-oil brand, as Conagra refocuses its business on
frozen meals and foods.
Rice Brothers Seek CEO Post, Board Shakeup at EQT
Toby and Derek Rice, who sold Rice Energy to EQT, have also
gained support of activist shareholder Elliott Management.
Volkswagen Supplier to Pay $35 Million Fine in Emissions-Cheating Probe
IAV, a Volkswagen supplier, has agreed to plead guilty and pay a
$35 million fine for its role in the German auto giant's
emissions-cheating scheme.
Regulator Fines Glencore Copper Unit $21.3 Million
Canada's main stock-market regulator issued a record $21.3
million fine to a Glencore-controlled copper-mining company to
settle allegations that it misled investors.
EQT, KKR Among Potential Bidders for Long Beach Container Terminal
Global investors including EQT Partners and KKR & Co. are
looking at bidding for the Long Beach Container Terminal in
Southern California, as are seasoned ship operators Seaspan and
Hyundai Merchant Marine.
Darden Says Diners Are Trading Up Amid Strong Labor Market
A strong labor market is pushing diners at Darden's restaurant
chains to splurge, helping overcome weaker traffic at Olive Garden
during its latest quarter.
Big Pharma Wins Drug Approval in China Ahead of West for First Time
China has approved AstraZeneca and Fibrogen's new anemia drug
roxadustat, marking the first time a medicine from a global
pharmaceutical company has received the green light there before
any other market.
(END) Dow Jones Newswires
December 18, 2018 21:15 ET (02:15 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.